Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation. 2022

Annelies C Wauters, and Jari F Scheerstra, and Irma G Vermeijlen, and Roel Hammink, and Marjolein Schluck, and Laura Woythe, and Hanglong Wu, and Lorenzo Albertazzi, and Carl G Figdor, and Jurjen Tel, and Loai K E A Abdelmohsen, and Jan C M van Hest
Bio-Organic Chemistry, Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands.

Nanosized artificial antigen-presenting cells (aAPCs), synthetic immune cell mimics that aim to activate T cells ex or in vivo, offer an effective alternative to cellular immunotherapies. However, comprehensive studies that delineate the effect of nano-aAPC topology, including nanoparticle morphology and ligand density, are lacking. Here, we systematically studied the topological effects of polymersome-based aAPCs on T cell activation. We employed an aAPC library created from biodegradable poly(ethylene glycol)-block-poly(d,l-lactide) (PEG-PDLLA) polymersomes with spherical or tubular shape and variable sizes, which were functionalized with αCD3 and αCD28 antibodies at controlled densities. Our results indicate that high ligand density leads to enhancement in T cell activation, which can be further augmented by employing polymersomes with larger size. At low ligand density, the effect of both polymersome shape and size was more pronounced, showing that large elongated polymersomes better activate T cells compared to their spherical or smaller counterparts. This study demonstrates the capacity of polymersomes as aAPCs and highlights the role of topology for their rational design.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D000938 Antigen-Presenting Cells A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors. Accessory Cells, Immunologic,Antigen-Presenting Cell,Immunologic Accessory Cells,Accessory Cell, Immunologic,Cell, Immunologic Accessory,Cells, Immunologic Accessory,Immunologic Accessory Cell,Antigen Presenting Cell,Antigen Presenting Cells,Cell, Antigen-Presenting,Cells, Antigen-Presenting

Related Publications

Annelies C Wauters, and Jari F Scheerstra, and Irma G Vermeijlen, and Roel Hammink, and Marjolein Schluck, and Laura Woythe, and Hanglong Wu, and Lorenzo Albertazzi, and Carl G Figdor, and Jurjen Tel, and Loai K E A Abdelmohsen, and Jan C M van Hest
April 2015, Small (Weinheim an der Bergstrasse, Germany),
Annelies C Wauters, and Jari F Scheerstra, and Irma G Vermeijlen, and Roel Hammink, and Marjolein Schluck, and Laura Woythe, and Hanglong Wu, and Lorenzo Albertazzi, and Carl G Figdor, and Jurjen Tel, and Loai K E A Abdelmohsen, and Jan C M van Hest
January 2014, ACS applied materials & interfaces,
Annelies C Wauters, and Jari F Scheerstra, and Irma G Vermeijlen, and Roel Hammink, and Marjolein Schluck, and Laura Woythe, and Hanglong Wu, and Lorenzo Albertazzi, and Carl G Figdor, and Jurjen Tel, and Loai K E A Abdelmohsen, and Jan C M van Hest
May 2023, Advanced healthcare materials,
Annelies C Wauters, and Jari F Scheerstra, and Irma G Vermeijlen, and Roel Hammink, and Marjolein Schluck, and Laura Woythe, and Hanglong Wu, and Lorenzo Albertazzi, and Carl G Figdor, and Jurjen Tel, and Loai K E A Abdelmohsen, and Jan C M van Hest
March 2024, ACS nano,
Annelies C Wauters, and Jari F Scheerstra, and Irma G Vermeijlen, and Roel Hammink, and Marjolein Schluck, and Laura Woythe, and Hanglong Wu, and Lorenzo Albertazzi, and Carl G Figdor, and Jurjen Tel, and Loai K E A Abdelmohsen, and Jan C M van Hest
April 2007, The Journal of experimental medicine,
Annelies C Wauters, and Jari F Scheerstra, and Irma G Vermeijlen, and Roel Hammink, and Marjolein Schluck, and Laura Woythe, and Hanglong Wu, and Lorenzo Albertazzi, and Carl G Figdor, and Jurjen Tel, and Loai K E A Abdelmohsen, and Jan C M van Hest
January 2014, Biomaterials,
Annelies C Wauters, and Jari F Scheerstra, and Irma G Vermeijlen, and Roel Hammink, and Marjolein Schluck, and Laura Woythe, and Hanglong Wu, and Lorenzo Albertazzi, and Carl G Figdor, and Jurjen Tel, and Loai K E A Abdelmohsen, and Jan C M van Hest
March 2020, Nature protocols,
Annelies C Wauters, and Jari F Scheerstra, and Irma G Vermeijlen, and Roel Hammink, and Marjolein Schluck, and Laura Woythe, and Hanglong Wu, and Lorenzo Albertazzi, and Carl G Figdor, and Jurjen Tel, and Loai K E A Abdelmohsen, and Jan C M van Hest
October 2018, Journal of visualized experiments : JoVE,
Annelies C Wauters, and Jari F Scheerstra, and Irma G Vermeijlen, and Roel Hammink, and Marjolein Schluck, and Laura Woythe, and Hanglong Wu, and Lorenzo Albertazzi, and Carl G Figdor, and Jurjen Tel, and Loai K E A Abdelmohsen, and Jan C M van Hest
December 1986, Agents and actions,
Annelies C Wauters, and Jari F Scheerstra, and Irma G Vermeijlen, and Roel Hammink, and Marjolein Schluck, and Laura Woythe, and Hanglong Wu, and Lorenzo Albertazzi, and Carl G Figdor, and Jurjen Tel, and Loai K E A Abdelmohsen, and Jan C M van Hest
January 2020, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!